Research Article
Stability-Indicating HPLC Determination of Gemcitabine in Pharmaceutical Formulations
Table 5
Factorial design data for robustness of chromatographic separation.
(a) |
| Selected parameters and their variations | −1 (lower limit) | +1 (upper limit) |
| Acetonitrile in mobile phase (%) () | 8 | 12 | Final pH of the mobile phase () | 6.8 | 7.2 | Column oven temperature (°C) () | 20 | 30 | Flow rate (mL/min) () | 0.8 | 1.2 |
|
|
(b) |
| Exp. number | Run order | | | | | | -D | -I |
| 1 | 6 | 8 | 6.8 | 20 | 0.8 | 14.01 | 1.12 | 1.2 | 2 | 11 | 12 | 6.8 | 20 | 0.8 | 13.1 | 1.11 | 1.19 | 3 | 5 | 8 | 7.2 | 20 | 0.8 | 14.1 | 1.09 | 1.18 | 4 | 13 | 12 | 7.2 | 20 | 0.8 | 13.2 | 1.08 | 1.1 | 5 | 1 | 8 | 6.8 | 30 | 0.8 | 14.3 | 1.09 | 1.11 | 6 | 7 | 12 | 6.8 | 30 | 0.8 | 10.2 | 1.09 | 1.08 | 7 | 10 | 8 | 7.2 | 30 | 0.8 | 14.5 | 1.11 | 1.15 | 8 | 15 | 12 | 7.2 | 30 | 0.8 | 11.85 | 1.1 | 1.08 | 9 | 12 | 8 | 6.8 | 20 | 1.2 | 13.51 | 1.13 | 1.11 | 10 | 14 | 12 | 6.8 | 20 | 1.2 | 10.21 | 1.05 | 1.07 | 11 | 9 | 8 | 7.2 | 20 | 1.2 | 14.41 | 1.09 | 1.12 | 12 | 2 | 12 | 7.2 | 20 | 1.2 | 10.05 | 1.06 | 1.07 | 13 | 8 | 8 | 6.8 | 30 | 1.2 | 13.25 | 1.12 | 1.1 | 14 | 4 | 12 | 6.8 | 30 | 1.2 | 10.15 | 1.04 | 1.07 | 15 | 3 | 8 | 7.2 | 30 | 1.2 | 14.12 | 1.1 | 1.11 | 16 | 16 | 12 | 7.2 | 30 | 1.2 | 10.15 | 1.05 | 1.05 |
|
|
: resolution factor, -D: tailing factor for drug, and -I: tailing factor for IS.
|